Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA070372-01
Application #
2114274
Study Section
Experimental Immunology Study Section (EI)
Project Start
1996-05-01
Project End
1999-04-30
Budget Start
1996-05-01
Budget End
1997-04-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Emory University
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Zimring, James C; Kapp, Linda M; Yamada, Masahisa et al. (2005) Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway. J Neuroimmunol 164:66-75
Kapp, Judith A; Kapp, Linda M; McKenna, Kyle C (2004) Gammadelta T cells play an essential role in several forms of tolerance. Immunol Res 29:93-102
Kapp, Judith A; Kapp, Linda M; McKenna, Kyle C et al. (2004) gammadelta T-cell clones from intestinal intraepithelial lymphocytes inhibit development of CTL responses ex vivo. Immunology 111:155-64
Zimring, James C; Levery, Steven B; Kniep, Bernhard et al. (2003) CD75s is a marker of murine CD8(+) suppressor T cells. Int Immunol 15:1389-99
Ma, H; Kapp, J A (2001) Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo. Cell Immunol 214:89-96
Ma, H; Kapp, J A (2000) Antigenic epitopes regulate the phenotype of CD8+ CTL primed by exogenous antigens. J Immunol 164:5698-703
Ke, Y; Ye, K; Grossniklaus, H E et al. (2000) Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses. Cancer Immunol Immunother 49:217-25
Ke, Y; Ma, H; Kapp, J A (1998) Antigen is required for the activation of effector activities, whereas interleukin 2 Is required for the maintenance of memory in ovalbumin-specific, CD8+ cytotoxic T lymphocytes. J Exp Med 187:49-57
Dombrowski, K E; Ke, Y; Brewer, K A et al. (1998) Ecto-ATPase: an activation marker necessary for effector cell function. Immunol Rev 161:111-8
Kapp, J A; Ke, Y (1997) The role of gammadelta TCR-bearing T cells in oral tolerance. Res Immunol 148:561-7

Showing the most recent 10 out of 12 publications